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ABSTRACT
￿
The receptor for a-latrotoxin, the major protein component of the black widow
spider venom, was investigated by the use of the purified toxin and of polyclonal, monospecific
anti-a-latrotoxin antibodies. Experiments on rat brain synaptosomes (where the existence of
a-latrotoxin receptors was known from previous studies) demonstrated that the toxin-receptor
complex is made stable by glutaraldehyde fixation . At saturation, each such complex was
found to bind on the average five antitoxin antibody molecules. In frog cutaneous pectoris
muscles, the existence of a finite number of high-affinity receptors was revealed by binding
experiments with ' 25 1-a-latrotoxin (Kd = 5 x 10-10 M; borax = 1 .36 ± 0.16 [SEJ x 109 sites/mg
tissue, dry weight). Nonpermeabilized muscles were first treated with a-latrotoxin, and then
washed, fixed, dissociated into individual fibers, and treated with anti -a-latrotoxin antibodies
and finally with rhodamine-conjugated sheep anti-rabbit antibodies. In these preparations,
muscle fibers and unmyelinated preterminal nerve branches were consistently negative,
whereas bright specific fluorescent images, indicative of concentrated a-latrotoxin binding
sites, appeared in the junctional region . These images closely correspond in size, shape, and
localization to endplates decorated by the acetylcholinesterase reaction. The presynaptic
localization of the specific fluorescence found at frog neuromuscular junctions is supported
by two sets of findings: (a) fluorescent endplate images were not seen in muscles that had
been denervated; and (b) the distribution of fluorescence in many fibers treated with a-
latrotoxin at room temperature was the one expected from swollen terminal branches. Swelling
of terminals is a known morphological change induced by a-latrotoxin in this preparation .
When muscles were treated with either proteolytic enzymes (trypsin, collagenase) or deter-
gents (Triton X-100) before exposure to a-latrotoxin, the specific fluorescent endplate images
failed to appear. Taken together these findings indicate that the a-latrotoxin receptor is an
externally exposed protein highly concentrated in the nerve terminal plasma membrane. Its
density (number per unit area) at the frog neuromuscular junction can be calculated to be
2,400/um2.
The presynaptic membrane is the portion of the neuronal
plasmalemma that surrounds synaptic terminals, where the
release of neurotransmitters occurs by fusion of synaptic
vesicles (exocytosis). A number of other important functions
(e.g., the recycling of the vesicle membrane, the high-affinity
uptake processes of neurotransmitters or transmitter precur-
sors, and the initiation of retrograde transport) are also local-
ized at this level. It is generally agreed that these functional
specializations of the presynaptic membrane occur as a con-
sequence ofits molecular dissimilarity with respect to the rest
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ofthe plasma membrane. However, a large gap of knowledge
still exists between these specifically localized functions and
the identification of the molecules involved in these functions
or otherwise specific for the presynaptic membrane (for a
recent review see reference 39).
In recent years natural neurotoxins have been widely used
in neurobiological studies (5, 15, 22, 27). Among the most
interesting features of these molecules are the high selectivity
and high affinity of interaction with unique membrane com-
ponents, their specific receptors. Thus, neurotoxins can be
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class of neurotoxins is known to act presynaptically (5, 15,
22, 27). Among these, a-latrotoxin (a-LTx),' from the venom
of the black widow spider, was found to act on many, and
possibly all, types of vertebrate synapses, where it induces
massive stimulation of quantal release of neurotransmitter
accompanied by parallel depletion of synaptic vesicles (9, 16,
22, 24, 29, 41, 45). In contrast, a-LTx is completely inactive
on axons and on nonneural cells, irrespective oftheir specific
properties (secretion, excitability, etc.) (16, 24, 34).
The mechanisms that mediate the widespread stimulatory
action of a-LTx at vertebrate synapses have been elucidated
only in part. A small number of specific, high-affinity binding
sites (henceforth referred to as the a-LTx receptors) have been
found in synaptosomes and pheochromocytoma cells (PC12)
(18, 34, 35, 42). Since the occupancy of these receptors
correlated in various experimental conditions with the sub-
sequent stimulation of transmitter release (34, 35), a causal
relationship between these two processes (possibly mediated
by the influx of divalent cations) appears quite likely. How-
ever, knowledge about a-LTx receptors is still very limited
and their presynaptic localization had never been demon-
strated. Here we report findings obtained by the use of mon-
ospecific anti-a-LTx polyclonal antibodies in rat cerebral
cortex synaptosomes and frog neuromuscular junctions
(NMJs). In agreement with the exclusively presynaptic effect
of the toxin, our results indicate that the high-affinity a-LTx
receptor is an externally exposed component of the nerve
terminal plasma membrane.
MATERIALS AND METHODS
Purification and Iodination of a-LTx and
Anti-a-LTx Ig
a-LTx was purified from homogenates of venom glands dissected out from
cephalotoraces of female European black widow spiders, Latrodectus mactans
tredecimguttatus, as described by FronWi et al. (16). The purity of the toxin
preparations was routinely assessed by SIDS PAGE. a-LTx affinity columns
were prepared by coupling the purified toxin to activated Sepharose 4B.
Anti-a-LTx Ig were raised in rabbits by three successive injections ofa-LTx
(25 ug, emulsified with complete Freund's adjuvant) given intradermally at
weekly intervals. Booster injections (50 t<g of a-LTx emulsified with incomplete
adjuvant) were given in the subscapular space. Anti-a-LTx sera were charac-
terized by Ouchterlony double diffusion, by crossed immunoelectrophoresis
(1), and by immunolabeling of SDS PAGE gels. For the latter test, 7.5-12%
polyacrylamide gradient slab gels bearing triplicate samples of crude venom
and purified a-LTx were cut longitudinally into three portions, one of which
was stained with Coomassie Brilliant Blue. The other two were fixed, exposed
to either the preimmune or to the anti-a-LTx serum and then to 12Sí-protein
A (1 x 106 cpm) as described by De Camilli et al. (12). Immunolabeled gels
were dried and autoradiographed on Kodak x-ray films for 20 h at -80°C.
Anti-a-LTx Ig were purified from immune sera by absorption onto a-LTx
affinity columns (overnight incubation at 2-3°C in a rotating apparatus) fol-
lowed by extensive washing in PBS and then by elution at low pH (200 mM
glycine-HCI buffer, pH 2.8).
a-LTx and anti-a-LTx Ig were iodinated by the Bolton-Hunter procedure
(3). As shown elsewhere (34), the labeled toxin retains full biological activity.
Analytical Procedures
Protein was measured according to Lowry et al. (30). SDS PAGE slabs were
prepared and run as described by Maizel (32). The biological activity ofa-LTx
was tested routinely on crude synaptosome preparations obtained from
Sprague-Dawley rat striatum. The synaptosomes were loaded in vitro with [3H]-
dopamine, exposed for 10 min at 37°C to various concentrations ofthe toxin,
'Abbreviations used in this paper.
￿
a-LTx, a-latrotoxin; mKR, mc d-
ified Krebs-Ringer medium; NMJ, neuromuscular junction; R, frog
Ringer's medium.
and then centrifuged for 5 min at 10,500 g in an Eppendorf microcentrifuge
(34). The pellets were washed once with incubation medium and their radio-
activity was counted in a Beckman SL 30 liquid scintillation spectrometer
(Beckman Instruments, Inc., Palo Alto, CA) (34).
Experiments on Rat Brain Synaptosomes
Pellets ofpurified synaptosomes, prepared from the cerebral cortex of rats
(20), were resuspended in a modified Krebs-Ringersolution (mKR) containing
(in mM): NaCl, 125; KCI, 5; MgS04 and KH2P04, 1 .2; CaC12, 2; HEPES-
NaOH buffer, pH 7.4, 25; glucose, 6; BSA, 0.02. Aliquots ofthese suspensions
were incubated under 100% 02 with a-LTx, 1251-a-LTx, or 12Sí-anti-a-LTx Ig
as described in Resultsand in the figure legends. 12Sí radioactivity was measured
in a Beckman GAMMA 4000 spectrometer (Beckman Instruments, Inc.).
Experiments on the Frog NM/
Experiments were made with cutaneous pectoris nerve-muscle preparations
from frogs, Rana pipiens (-20 g body wt). Muscles were mounted in Lucite
chambers previously described (23) and bathed in Ringer's solution (R), pH
7.0, containing (in mM): NaCl, 116; KCI, 2.1; CaC12, 1.8; NaH2P04, 1;
Na2HP04, 2. When the ionic composition of the R solution was modified, the
concentration ofNaCI was adjusted to keep the tonicityconstant. To denervate
muscles, we cut the II and III spinal nerves ofanesthetized frogs near the spinal
cord and removed 1 cm of the common trunk. After 18-20 d the success of
denervation was evaluated in all musclesby visual inspection underadissecting
microscope. Some muscles were also mounted in the Lucite chamber and
observed under a Zeiss microscope equipped with Nomarski optics. In other
muscles, fibers were impaled near remnants of nerve branches to ascertain the
absence ofminiature endplate potentials.
Electrophysiology
Intracellular recording of miniature endplate potentials at the endplate
region was used to test the activity of a-LTx and 12Sí-a-LTx. Specific activity
was defined as previously described (23). In these experiments a modified R
containing0.7 mM Ca2' and 4 mM Mp~' was used. To determine the effect of
anti-a-LTx sera, we recorded the indirectly evoked compoundaction potentials
in cutaneous pectoris muscles exposed to a-LTx as previously described (8).
Immunocyfochemistry
The muscles, mounted in Lucite chambers, were incubated for 1 h either at
2-3°C or at room temperature in R solution containing BSA, I mg/ml, and a-
LTx, 2.5 or 7.5 x 10-' M. These concentrations roughly corresponded to 3.5
and 10 times the threshold dose for a-LTx at the frog NMJ. The chamber was
then drained and refilled with the same solution without toxin every 5 min (six
to eight washes). Subsequently the muscles were fixed with 2% glutaraldehyde
in 0.1 M sodium phosphate buffer, pH 7.3. After fixation the muscles fibers
were teased apart under a dissecting microscope by means of bent insect pins
mounted on wooden sticks. Single fibers were then transferred to plastic
Eppendorftubes.
The bound toxin was revealed by indirect immunofluorescence using rabbit
anti-a-LTx antisera and rhodamine-conjugated sheep anti-rabbit antibodies.
To quench the aldehyde groups offixatives, the muscle fibers were first soaked
in glycine (0.1 M, pH 7.4, 10 min), washed with phosphate buffer (0.1 M, pH
7.3), then soaked in sodium borohydride (1%, 10 min, at 0°C), and finally
extensively washed with phosphate buffer. Anti-a-LTx serum was diluted 1:10
with phosphate buffer (20 mM, ph 7.3) containing 0.5 M NaCI and 17% normal
goat serum. After incubation at 37°C for I h, the fibers were washed for an
additional hour with the 0.5 M NaCl, 20 mM phosphate buffer solution.
Subsequently, rhodamine-conjugatedsheep anti-rabbitantibodies(diluted 1:2.5
with the same solution used for the first antiserum) were applied at room
temperature for 1 h. After being washed overnight with the 0.5 M NaCI-20
mM phosphate buffer solution containing 0.1% Triton X-100, the fibers were
mounted on microscope slides in 95% glycerol-5% PBS and examined with a
Zeiss Photomicroscope III equipped with fluorescence epiillumination. Two
sets ofcontrols were run concomitantly with the experimental samples. In the
first, the anti-a-LTx serum was replaced by preimmune serum; in the second,
the muscle was not exposed to the toxin before treatment with anti-a-LTx
serum.
Cholinesterase Staining
Cutaneous pectoris muscles were fixed with 4% formaldehyde (freshly
prepared from paraformaldehyde) in 0.1 M phosphate buffer, pH 7.3, and
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terminals was followed under a dissecting microscope and the reaction was
stopped by extensive washing in 0.44 M sucrose .
Morphometric Analyses
DETERMINING THE NUMBER OF MUSCLE FIBERS IN THE CUTA-
NEOUS PECTORIS MUSCLE : Five muscles pinned to a Sylgard layer in the
bottom ofa Petri dish were fixed for 1 h with a cold (4°C) solution of2% OsO4
in 0 .1 mM phosphate buffer, pH 7 .3 . Each muscle was longitudinally cut into
three parts which were dehydrated and stacked for embedding in Epon. Semi-
thin sectionswere cut perpendicular to the majoraxis ofthe fibers, stainedwith
toluidine blue, and photographed in a Zeiss photomicroscope III . Fibers were
then counted on the printed micrographs . The average number of fibers in
individual muscles was found to be 517 ± 43 (SD) .
DETERMINING THE SURFACE AREA OF THE NERVE TERMINAL
BRANCHES : To obtain a rough estimate ofthe total surface area ofterminal
branches in one end plate, we considered the entire terminal arborization a
cylinder with the height being the sum of the length ofthe individual branches .
The length and number ofthe branches were determined on the photomicro-
graphs of 10 terminals revealed by the cholinesterase reaction . The average
length of the total arborization per terminal was 639 um ± 180 (SD). This
estimate is in good agreement with previous findings (28). The value of the
circumference used tocompute the surfaceareawas the average of20perimeters
ofcross-sectioned resting terminals measured on printed electron micrographs
(4 .0 gem t 1 .1, SD) . Fixation and processing of the muscles for electron
microscopy are described elsewhere (4) .
MEASUREMENT OF THE AVERAGE TRANSVERSE DIMENSION OF FLU-
ORESCENT NERVE TERMINALS : In order to assess the degree of swelling
induced by a-LTx (9, 16, 24), the transverse dimension ofimmunofuorescent
terminals that had been exposed to a-LTx at either 2-3°C or room temperature
was measured on printed micrographs (x 400) of front viewed terminals (see
Fig . 8, C and D) . Measurements were made normal to the major axis of
individual branches, at 2-mm intervals . For the two experimental conditions a
total of 300 and 270 measurements were made in portions ofbranches from 8
and 7 NMJs, respectively.
a-LTx Binding
Entire cutaneous pectoris muscles were incubated for 90 min at 0°C in
Eppendorf plastic tubes containing 200 gel of R solution supplemented with
BSA (1 mg/ml), with a fixed amount of ' 251-a-LTx and various amounts of
nonradioactive a-LTx . Final concentrations of the toxin ranged from 10- ' ° to
4 x l0-' M . After this incubation the muscleswere washed extensively (3 h ; 10
washes) at 0°C, first with R solution containing BSA, then with double distilled
water. Subsequently, the muscles were freeze-dried, weighed in a Cahn analyt-
ical microbalance (Cahn Instruments, Inc., Cerritos, CA), and finally counted
in a Beckman GAMMA 4000 spectrometer. Unspecific binding was estimated
by counting radioactivity in muscles exposed for 1 h to a large excess of
unlabeled toxin (5 x 10-8 M) before incubation with `I-a-LTx . Specific
binding is defined as the difference between total and unspecific binding,
expressed as femtomoles of a-LTx per milligram ofmuscle tissue dry weight.
Materials
The following materials were purchased from the sources indicated below :
Bolton-Hunter reagent, N-succimidyl 3-(4-hydroxy-5-[' 25I]iodophenyl)-
propionate (specific radioactivity : 1,500 Ci/mmol) and ethylamine 1,2-['H]-
dopamine HCl (specific radioactivity: 3.2 Ci/mmol): The Radiochemical
Centre, Amersham, Bucks, U.K . ; "5I-Protein A, various Sephadex gels, and
activated Sepharose 4B: Pharmacia Inc., Uppsala, Sweden; lowM agarose,
high and low gel temperature : Bio-Rad Laboratories, Richmond, CA ; 8%
glutaraldehyde vials, electronmicroscopy grade : Polysciences, Inc ., Warrington,
PA ; trypsin : Boehringer, Darmstadt, Federal Republic of Germany; soybean
trypsin inhibitor: SigmaChemical Co ., St. Louis,MO ; rhodamine-labeled sheep
anti-rabbit Ig, purchasedfrom Dako, Copenhagen, Denmark, were bound onto
a Sephadex DE52 column and eluted with phosphate buffer (10 mM, pH 7 .4)
containing 100 mM NaCl. Crude collagenase (type III, Sigma Chemical Co .)
was purified asdescribed by Schultz et al . (40). All other chemicals were reagent
grade .
RESULTS
Characterization ofAnti-a-LTx Sera and Purified Ig
The specificity of the anti-a-LTx sera and Ig was investi-
gated by various methods. Ouchterlony double diffusion of
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antisera against total black widow spider venom and purified
a-LTx yielded single precipitation lines, which appeared at
serum dilutions up to 1 :16 and 1 :32 (not shown) . Crossed
immunoelectrophoresis of the sera against total venom gave
rise to two arcs of precipitation which, however, were contin-
uous with each other (Fig . 1), indicating that the two respon-
sible antigens had common determinants. This result con-
firms the microheterogeneity of a-LTx, which is known to
contain at least two closely related components, similar in
size but slightly different in charge (16) . The monospecificity
of the antibody was also shown by immunolabeling of SDS
PAGE slabs, first soaked in the immune serum and then
overlayed with 125I-protein A . As can be seen in Fig. 2, the
immune serum, when applied to the total venom homogenate
(which gives a gel pattern ofover 20 major bands) only bound
to the large a-LTx band and to a minor doublet of slightly
smallerM r . The latter is probably a degradation product of
a-LTx, since it was found only in some preparations and
tended to increase with storage . No radioactive bands ap-
peared in the control gels treated with the preimmune serum .
The ability of anti-a-LTx sera and purified Ig to interfere
with the action of a-LTx was studied in both synaptosomes
and NMJs . Immune sera and the purified Ig, when mixed
with the toxin in appropriate concentrations, were found to
prevent the release response from synaptosomes and to pre-
vent transmission block at the NMJ (Fig. 3) . The block of the
indirectly evoked compound action potential induced by a
supramaximal dose of a-LTx was almost completely pre-
vented by the anti-a-LTx immune serum . In contrast, the
preimmune serum, as well as the immune serum that had
been depleted of anti-a-LTx Ig by immunoadsorption onto
an a-LTx-Sepharose column, were without effect .
Experiments on Rat Brain Synaptosomes
The experiments on synaptosomes were carried out with
the following two purposes : (a) to obtain information on the
interaction of a-LTx with its receptor and with the anti-a-
FIGURE 1
￿
Crossed immunoelectrophoresis of anti-a-LTx Ig against
total black widow spider venom gland homogenate . An aliquot (40
leg) of the gland homogenate prepared according to Frontali et al .
(16) was electrophoresed in the first dimension . The separated
antigens were then electrophoresed in the Ig-containing gel (3 .5 ml
of 1 .1% agarose with 150 gel of rabbit anti-a-LTx serum) . Material
was run toward the anode because preliminary experiments
showed no precipitation areas when electrophoresis was performed
in the opposite sense . Coomassie Blue staining .FIGURE 2
￿
Coomassie
Blue staining and anti-
body-1251-protein A ra-
dioimmunolabeling of an
SIDS polyacrylamide gel . A
7.5-12% polyacrylamide
gradient slab gel was
loaded with duplicate sam-
ples of black widow spider
venom gland homogenate
(60 jg protein, lanes A and
D) and purified a-LTx (4 jug
protein, lanes B and C .
After electrophoresis the
gel was cut longitudinally .
One part (lanes A and 8)
was stained with Coomas-
sie Blue, another part was
processed for immunola-
beling with anti-a-LTx
serum followed by 1251-pro-
tein A (lanesC and D) . The
arrow on the right marks
the position of a-LTx . Hor-
izontal bars correspond to
the positions of four stand-
ards : from top to bottom,
R-galactosidase, BSA, oval-
bumin, and chymotrypsi-
nogen .
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FIGURE 3
￿
Effects of a-LTx (3 nM) on neuromuscular transmission
when applied in R solution together with different sera (33 jullml) .
Ordinate : amplitude of the compound action potential of the mus-
cle evoked by indirect stimulation normalized to the amplitude
recorded immediately before a-LTx was added (O) . Abscissa : time
in minutes after adding a-LTx . A, a-LTx plus preimmune serum ; ",
a-LTx plus anti-a-LTx serum;*, a-LTx plus anti-a-LTx serum de-
pleted of anti-a-LTx Igs by immunoabsorption onto an a-LTx-
Sepharose column .
LTx Ig and (b) to set up experimental conditions for the
studies at the NMJ.
Central to the problem of receptor localization by means
of anti-a-LTx is the stability of the toxin binding to its
receptor. Therefore we first addressed our experiments in this
direction . Synaptosome suspensions were exposed to ' ZSI-a-
LTx and then embedded in thin agarose films (10) in order
to facilitate transfer through a series ofwashing solutions. The
results are illustrated in Fig. 4 . In agreement with previous
findings (34, 42), we observed that the binding of a-LTx to
its receptor is very stable during incubation in physiological
so~
PBS+
￿
P8S " PBS,
01M lysine
￿
PBS
￿
04M 8aC1 03%Triton
3
hours
FIGURE 4
￿
Effects of various treatments on the dissociation of
12s1-
a-LTx . Freshly prepared synaptosome suspensions in mKR (1 ml,
4.62 mg protein) were labeled with ' 251-a-LTx (10- '° M ; 9 x 105
cpm) for 30 min at 0°C, then centrifuged (10,500 g, 5 min), washed,
and resuspended in the same volume of mKR . 100-,uI aliquots
(containing 38,500 cpm) were mixed with 10 IAI of either 20%
formaldehyde, 20% glutaraldehyde (both in 125 mM phosphate
buffer, pH 7 .4), or plain phosphate buffer. Additional samples were
prepared by diluting 100 uI aliquots of 1251-a-LTx in mKR (40,000
cpm), containing no synaptosomes, with 10 ul of either formalde-
hyde, glutaraldehyde, or mKR . After 30 min at room temperature
the samples were heated at 38°C and mixed with 100 jul of 3%
fluid agarose, and the mixtures were poured in the space remaining
between two coverslips sandwiched between two microscope
slides held in position by spring clips. After gelation (30 min at 0°C)
the agar layer was recovered, sliced with a razor blade, and incu-
bated at 0°C in the solutions indicated at the top of the figure. O,
free, unfixed a-LTx ; " , unfixed synaptosomes; A, synaptosomes
fixed with formaldehyde ; ", synaptosomes fixed with glutaralde-
hyde . The data obtained with free a-LTx exposed to fixatives before
agar embedding were almost identical to those for the free unfixed
a-LTx samples (O) .
media . However, when agar strips containing synaptosomes
were transferred to high salt medium, 20% ofthe bound toxin
was readily released . Most ofthe remaining toxin was released
during a further incubation in a medium supplemented with
the non-ionic detergent Triton x-100, which can be used for
permeabilization and washing in immunofluorescence tech-
niques . Different results were obtained with synaptosomes
that, after a-LTx treatment and washing, had been fixed
before embedding in agar . When synaptosomes were fixed
with formaldehyde, the high salt-induced release disappeared,
and the Triton-induced release was decreased ; after glutaral-
dehyde, even the latter was almost entirely prevented . Thus,
glutaraldehyde fixation appeared as an adequate procedure
for preserving the a-LTx-receptor complex .
A second point to be investigated was the kinetics of the
anti-a-LTx Ig interaction with the a-LTx-receptor complex.
We found that synaptosomes that had been previously ex-
posed to the toxin were able to specifically bind ' ZSI-anti-a-
LTx Ig, whereas untreated synaptosomes were not (Fig. 5 left).
Moreover, this Ig binding was not appreciably affected by
fixation of a-LTx-treated synaptosomes with either formal-
dehyde or glutaraldehyde (data not shown) . Fig. 5 illustrates
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FIGURE 5 1251-anti-a-LTx Ig binding to a-LTx-treated synapto-
somes: time course (left) and concentration dependence (right) .
Pellets of freshly prepared purified synaptosomes were resus-
pended in mKR (11 mg protein/ml) and treated with a-LTx (8 x
10-9 M) at 0°C for 30 min. After centrifugation (10,500g, 5 min),
washing, and resuspension in mKR, they were divided into aliquots
(55 leg of protein, 200 jut) which were exposed to affinity-purified
1251-anti-a-LTx Ig. (Left) In these experiments 20 ng (18,000 cpm) of
1251-anti-a-LTx Ig was used; the incubations were carried out for
the indicated time periods first at either 37°C (E7) or 22°C (/) and
then at 4°C (dashed lines). 100% specific binding = 9,200 cpm.
(Right) In these experiments the concentration of 1251-anti-a-LTx Ig
varied in the range indicated in the abscissa; the incubations were
carried out at 37°C for 90 min. For both panels, values shown are
differences between total binding and unspecific binding, i.e., the
1251-anti-a-LTx binding measured in the presence of 4.5 jug of
unlabeled anti-a-LTx Ig (averages of two experiments). During the
experiments shown on the left, the unspecific binding increased
from 750 to 2,250 cpm ; in the experiments on the right, it varied
between 7 and 16% of the specific binding.
the time course (left panel) and the concentration dependency
(right panel) ofthe"'I-Ig specific binding. At 37°C the binding
interaction saturated after -90 min, while at room tempera-
ture a longer time was needed. In synaptosomes exposed to
saturating concentrations of first a-LTx and then anti-a-LTx
Ig, almost 5 pmol ofthe latter was found to bind per milligram
of synaptosomal protein . Since the maximal specific binding
of a-LTx to rat cerebral cortex synaptosomes is 0.88 pmol/
mg protein (34), these results indicate that at saturation, five
molecules of Ig are bound per each a-LTx-receptor complex.
Experiments on Frog NMI
BINDING OF a-LTX :
￿
The frog cutaneous pectoris nerve-
muscle is the experimental preparation in which the presyn-
aptic effect of a-LTx was originally discovered and then
extensively investigated (6, 7, 9, 16, 17, 24, 29). However,
untilnow, no direct information was available on the binding
of the toxin in this preparation. Biochemical experiments
were therefore carried out as a necessary complement to the
immunofluorescence data reported below.
Intact muscles (which are three to four fibers thick) were
incubated at 0°C with labeled a-LTx (Fig. 6). A specific
binding was detected which approached saturation at concen-
trations in the nanomolar range. When analyzed according
to Scatchard, the data fell along a straight line, suggesting the
existence in the preparation of a single class of high-affinity
receptors (brnax : 1.36 ± 0.16 x 109 sites/mg of muscle tissue,
dry weight (average ± SE of four experiments); Ka = 5 x
10- '° M). This high-affinity . binding was not detected in
muscles that had been successfully denervated.
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FIGURE 6
￿
a-latrotoxin binding to cutaneous pectoris muscle as a
function of toxin concentration. Entire muscles were incubated for
90 min at 0°C in 200 Iu1 of R solution supplemented with BSA and
containing a fixed amount of 1251-a-LTx (150,000 cpm; 40 pM) as
well as nonradioactive a-LTx, to the final concentrations indicated
in abscissa. Total (9) and unspecific (0) binding are shown. Each
symbol represents the average of values obtained in two muscles
during a single experiment.
In the frog cutaneous pectoris muscle, NMJs are easy to
identify because of their characteristic structure (14, 31, 38).
The motor axon loses its myelin sheet at some distance from
the muscle fiber. The preterminal unmyelinated axon divides
each side into several branches which make contact with the
muscle fiber after running free for many micrometers. The
true terminal branches, which are a few hundred micrometers
long, run almost parallel to the major axis of the muscle fiber.
In Fig. 7 the typical aspect of the terminal branching is
revealed by the acetylcholinesterase reaction. The preterminal
arborization occupies the cholinesterase-negative region to-
wards the middle of the endplate (31).
Fig. 8 shows fibers from preparations that had been treated
first with a-LTx, then with anti-a-LTx serum, and finally
with rhodamine-conjugated sheep anti-rabbit Ig. Two exper-
imental conditions were investigated. In the first (Fig. 8, A-
C) the muscle was exposed to the toxin at 2-3°C, in the second
at room temperature. The immunofluorescence pattern on
the fibers of muscles treated in the cold closely resembled the
images revealed at rest by the cholinesterase reaction (Fig. 7).
The muscle fibers were uniformly negative, and very little or
no fluorescence was observed on either the preterminal
branches (Fig. 8, A and B) or the residual portions of motor
axons (Fig. 8, C and D). In contrast, a bright fluorescence
appeared over the entire terminal arborization. In different
endplates, and even in different portions ofthe same endplate,
the distribution ofthe labelwas appreciably variable. At some
sites the fluorescence appeared almost uniformly distributed
(Fig. 8, A and B), while at some others it showed a punctate
pattern (Fig. 8 C or was concentrated in two parallel rows
marking the edges of the terminal branches (Fig. 8 C.
In the fibers ofmuscles that had been exposed to a-LTx at
room temperature, the overall pattern of terminal branching
revealed by immunofluorescence (Fig. 8 D) was analogous to
that described for the muscles treated in the cold. However,
the prominence of the fluorescence along the edges of the
terminals was frequent and very marked in the fibers exposed
at room temperature. Moreover, the transverse dimension of
these terminal branches was obviously increased. This change,FIGURE 7
￿
Light micrograph of an"NMJ on a single fiber teased from cutaneous pectoris muscle of Rana pipiens . The terminal
branching of the motor nerve is revealed by the cholinesterase reaction according to Karnowsky and Roots (26) . Note the lack of
cholinesterase activity in the region between the two arrowheads . This region is where the unmyelinated preterminal axon
branches to form the terminal arborization . Compare this figure with Fig . 8 . x 330.
however, was not uniform along the entire length of the
branches, and swollen portions were frequently continuous
with portions of smaller size, where fluorescence appeared
more uniformly distributed (Fig . 8D). ' The difference in ap-
parent transverse dimension offluorescent terminal branches
between preparations exposed to a-LTx at either 2-3°C or
room temperature was further substantiated by the results of
a morphometric analysis.The average dimensions (Am ± SD)
were 5.3 ± 1 .3 in the preparations treated in the cold, and 10
± 2.2 in those treated at room temperature. These dimensions
are 5-10 times the diameters of terminals measured from
electron micrographs . They must overestimate the true di-
ameters since they include the fluorescence halo . They were
measured to provide a rough index of:swelling that occurred
in the two conditions .
Two types of controls were used in order to ascertain the
specificity ofthe immunofluorescence images so far described .
In the first, the muscles were fixed and' exposed to the anti-
bodies without prior treatment with a-LTx ; in the second, a-
LTx treatment was made as usual, but the first serum was not
the anti-a-LTx but the rabbit preimmune serum . Under both
these conditions the preparations appeared uniformly nega-
tive .
Since the immunofluorescence images illustrated in Fig. 8
were suggestive of a specific localization of a-LTx binding at
the endplate region, it seemed imperative to perform experi-
ments in muscles that had their motor iiérve trunks removed
20 d before the experiments and that were therefore dener-
vated according to the criteria speciftéd in Materials and
Methods . In these muscles no specific,-immunofluorescence
images were ever observed .
A further series ofexperiments aimed _to unravel the nature
ofthe a-LTx receptor was carried out by pretreatment of the
normally innervated muscle preparations with proteolytic
enzymes before exposure to a-LTx . Both trypsin (100 Ag/ml ;
1 h, room temperature, followed by soybean trypsin inhibitor,
200 ug/ml, to block the reaction) and purified collagenase
(0.3 mg/ml, 1 h, room temperature) entirely prevented the
appearance of the specific immunofluorescent images . In
contrast, normal images were seen in muscles preincubated
with trypsin together with its inhibitor . Finally, pretreatment
with detergent was also studied . In muscles preincubated with
TritWX-100 (0.5%, 1 h, room temperature) and then exten-
sively'washed with R, exposed to a-LTx in the cold, and
processed for immunofluorescence as described above, no
labeled endplate images were ever observed .
DISCUSSION
In the present paper we report biochemical, immunochemical,
and immunocytochemical studies on the a-LTx receptor,
carried out by the use of the purified toxin in conjunction
with monospecific antibodies against a-LTx . Two experimen-
tal systems were investigated : rat cerebral cortex synaptosomes
and frogNMJ . Our initial purpose was to obtain complemen-
tary data on the two systems . These systems appear to be
similar because (a) the effects produced by the toxin are
analogous (compare references 9, 24, and 29 with references
2, 19, 34, and 41) ; (b) the two systems are sensitive to
approximately the same concentrations of a-LTx (16, 34, 41,
45) ; and (c) the high-affinity receptors have similar kinetic
features (compare the data on a-LTx binding in this paper
with references 34 and 42) .
Stability of Antibody-Toxin-Receptor Complex
Part of the experiments we carried out on synaptosomes
were aimed to characterize the receptor-a-LTx-anti-a-LTx
Ig interaction and thus to define conditions appropriate for
the immunocytochemical studies . In particular, from these
studies we learned that the stability of the a-LTx-receptor
binding could be preserved by glutaraldehyde fixation without
impairment of the subsequent recognition ofthe bound toxin
by the specific Ig . This observation was important in setting
up the experimental protocol that was successfully used for
the immunofluorescence studies at frogNMJ. However, when
this protocol was applied to synaptosomes (criosections of
centrifugation pellets or synaptosomes attached to polylysine-
coated slides), the results were disappointing because of the
low ratio between specific signal and background fluores-
cence. This failure is probably due to the low density of a-
LTx receptors in the rat synaptosome plasma membrane (34) .
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12 9FIGURE 8 a-LTx immunofluorescence in NMIs on single fibers teased from cutaneous pectoris muscle of Rana pipiens . The
muscles were incubated at 2-3°C (A-C) or at room temperature (D) for 1 h in R solution containing a-LTx (7.5 x 10-'M), washed,
and fixed in 2% glutaraldehyde . Then the fibers were teased apart . The bound toxin was revealed by indirect immunofluorescence .
The regions of intense fluorescence are arranged in a branching pattern characteristic of frog motor nerve endings . In A and 8
note the paucity of fluorescence in the region between the arrowheads corresponding to the location of the unmyelinated
preterminal branches (compare with Fig . 7) . In C andD the residual portions of motor axons are evident (arrows) . The prominence
of fluorescence along the edges of the terminal is particularly evident in the preparation treated with the toxin at room temperature
(D) . Little fluorescence is associated with the muscle fibers and with the residual portions of the axons . x 350 .
130Experiments on the NMJ
Biochemical experiments with a-LTx demonstrated the
existence of a single class of high-affinity a-LTx receptors in
innervated frog muscles. Occupancy of these receptors oc-
curred in the 10-'°-10-9 molar range of a-LTx. This finding
is in good agreement with the concentration dependency of
the toxin-induced release of quanta of acetylcholine (see ref-
erences 16 and 24). This high-affinity binding disappeared
after denervation.
The bound toxin was revealed by immunofluorescence only
in the end plate region of the muscle. The muscle fibers, as
well as the myelinatedaxons, were consistently negative. Little
or no fluorescence was found in the central region of the
endplate. This area, which is also negative for acetylcholines-
terase and which contains no postsynaptic folds when ob-
served at the electron microscope level, is the site where the
preterminal unmyelinated fibers branch before making the
synaptic contact with the muscle fiber.
In our experimental conditions a-LTx as well as Ig were
applied before any membrane permeabilization of the tissue.
Thus, the receptor responsible for toxin binding was exposed
at the external surface, and could not be a secluded compo-
nent of the cytoplasm. The lack of immunofluorescence ob-
served when the muscles were treated with Triton X-100
before the application of a-LTx indicates that the receptor is
an integral membrane component, and its sensitivity to pro-
teolytic enzymes suggests that it is probably a protein. This
conclusion is in line with previous data on synaptosomes and
PC12 cells (34, 35, 42).
The resolution of immunofluorescence is not adequate to
answer directly the question of whether the a-LTx receptor is
localized in the membrane of terminal branches or in other
structures of the endplate region (postsynaptic membrane,
Schwann cells). Indeed, a presynaptic binding has been sug-
gested in the past for several reasons: (a) the massive stimu-
lation of secretion of quanta of acetylcholine, which ulti-
mately results in the depletion of the total quantal store of
the terminals; (b) the lack of effect of a-LTx on muscle
electrophysiology and contractile properties; and (c) the strik-
ing ultrastructural changes, which are restricted to the nerve
terminals, with no obvious changes of muscle fibers and
Schwann cells (for review see reference 24). The present work
provides two further pieces ofevidence supporting the a-LTx
binding to the presynaptic membrane. These are (a) the
concomitant disappearance of specific, high-affinity binding
and immunofluorescence after denervation, and (b) the swell-
ing of the immunofluorescent terminal branches, which was
particularly evident in the preparations exposed to a-LTx at
room temperature. These results are in good agreement with
those of previous ultrastructural studies on the frog NMJ
exposed to the toxin, which showed depletion of synaptic
vesicles accompanied by profound terminal swelling (9, 16).
Further support for the identification of the room-tempera-
ture fluorescence figures as swollen presynaptic terminals
comes from the sharp local differences in transverse dimen-
sion observed in adjacent portions of individual branches.
Since the increase in the surface area, accompanied by a
swelling ofthe terminal, is due to localincorporation of vesicle
membrane into the axolemma, the sharp differences in the
transverse dimension might be the consequence of the abrupt
variation in the vesicles concentration which is knownto exist
in the different portions of individual terminal branches (4).
Suggestions have been made about a possible localization
of a-LTx receptors at discrete sites of the presynaptic mem-
brane (42). The resolution ofimmunofluorescence is certainly
too low to definitely set this issue. However, we wish to
emphasize that the images we have obtained failed to reveal
a constant, ordered pattern of fluorescence, as would be
expected in the case of a nonrandom distribution of the a-
LTx receptors. To calculate the density (number per unit
area) of the receptors, we have therefore assumed that they
are uniformly distributed over the entire plasma membrane
ofthe synaptic terminal. Our measurements indicate that one
cutaneous pectoris muscle (average dry weight: 2.36 mg)
contains 517 ± 43 (SD) fibers. Each of these fibers is endowed
with one endplate. The surface area of an individual terminal
arborization (estimated as described in Materials and Meth-
ods) is on the order of 2,500 jum2. Thus, the high-affinity
binding sitesthat we have found (3.21 x 109 sitesper muscle)
should be distributed in a total surface area of 1 .32 x 106
Amt, with a density of 2,400/,um2. Although unexpected,
this high density does not seem unreasonable in view of two
simple considerations: (a) in nerve-muscle preparations, the
total surface area of nerve terminals is a small fraction ofthe
total membrane surface area, and thus it would be difficult to
detect high-affinity binding sites with low density; (b) the
intense immunofluorescent specific signal obtained from our
single muscle fibers is only compatible with a relatively high
receptor density. Indeed, in rat brain synaptosomes and in
PC 12 cells where the a-LTx receptor density was found to be
much lower (20-30/Am
2 and 12/Am', respectively) (34, 35),
the immunofluorescent signal was undetectable.
In conclusion, the data that we have reported support the
view that the a-LTx receptor is a protein highly concentrated
at the plasma membrane of synaptic terminals, where it is
exposed at the external surface. Other molecules specific for
the presynaptic compartment have been recently described.
Synapsin I, which is a substrate for both Ca"- and cAMP-
dependent protein kinases, is now recognized to be a periph-
eral membrane protein located at the cytoplasmic surface of
synaptic vesicles in many (and possibly all) synapses (10, 11,
25). Another widely distributed protein exposed at the cyto-
plasmic surface of synaptic vesicles has been recognized by
the use of monoclonal antibodies (33), and one antigen has
been localized at the inner surface of the same organelles by
polyclonal antibodies (21). Moreover, an internally exposed
glycosaminoglycan has been recognized in cholinergic syn-
aptic vesicles (43, 44). In the presynaptic membrane of syn-
aptosomes from Torpedo electric organ, one specific protein
band has been identified by SDS PAGE analysis (36) and one
antigen (possibly a ganglioside) by immunocytochemistry
(43). Very recently it has been reported that two other neu-
rotoxins bind specifically to the plasma membrane of nerve
terminals: botulinum toxin to mouse NMJ (13) and glycero-
toxin to synaptosomes from Torpedo electric organ (37). Our
data and these recent findings indicate that toxin receptors
are specific components of the plasma membrane of synaptic
terminals. Thus it seems that neurotoxins are important tools
for the investigation of not only the process of transmitter
release, but also the topological specialization of the nerve
terminal plasma membrane with respect to the remaining
portions of the axolemma.
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